Alvotech and Dr. Reddy’s collaborate for commercialization of AVT03 (denosumab)
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
The award recognizes powerful science–industry collaborations for social good
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
The demand in Africa for COVID-19 vaccines has declined
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
The average time of dilation lasts three to eight hours
Subscribe To Our Newsletter & Stay Updated